Aster Capital Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Other funds holding IART
Aster Capital Management's IART Position: Q3 2026 in Review
Aster Capital Management sold out of Integra LifeSciences (IART) in Q3 2026, closing a stake of 742 shares — an estimated $13.3K sold.
Aster Capital Management first reported a position in IART in Q3 2024 and held it in 3 quarters. The position peaked at $22K in Q2 2025. 234 funds tracked by Wall St. Rank hold IART as of Q3 2026.
- Aster Capital Management reported no remaining Integra LifeSciences position as of Q3 2026 after selling out during the quarter.
- Aster Capital Management sold 742 Integra LifeSciences shares in Q3 2026, an estimated $13.3K.
- Aster Capital Management first reported a position in Integra LifeSciences in Q3 2024 and held it in 3 quarters.
- Aster Capital Management's Integra LifeSciences position peaked at $22K in Q2 2025.
- 234 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.